Resource impact statement

No significant resource impact is anticipated

We do not expect this guidance to have a significant impact on resources; that is, it will be less than £5m per year in England (or £9,100 per 100,000 population). This is because we do not anticipate a significant change in practice as a result of the guidance. The recommended immunosuppressive therapy treatments are already available on the NHS for adults having a kidney transplant.

The number of people eligible for treatment is estimated to be around 2,700 for England.

These technologies are commissioned by NHS England. Providers are specialised tertiary care units.


This page was last updated: